Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Long-Term Debt Repayments (2025 - 2026)

Updated

Analysis

Odyssey Therapeutics (ODTX) Long-Term Debt Repayments (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 1.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -4.91 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 19.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn - 47,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 47,000.00
Jun 30, 2026 46,000.00
Mar 31, 2026 24,000.00
Sep 30, 2025 37,000.00
Jun 30, 2025 35,000.00
Mar 31, 2025 35,000.00
API Access

Odyssey Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ODTX&period=max&api_key=YOUR_API_KEY